Spots Global Cancer Trial Database for dermatology
Every month we try and update this database with for dermatology cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| High- and Low-risk Actinic Keratosis Referrals to Secondary Care | NCT05976061 | Actinic Keratos... | 18 Years - | Maastricht University Medical Center | ||
| A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand | NCT00544297 | Actinic Keratos... | PEP005 gel | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses | NCT00107965 | Actinic Keratos... | PEP005 PEP005 PEP005 PEP005 PEP005 PEP005 PEP005 PEP005 | 18 Years - | Peplin | |
| Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma | NCT01863108 | Melanoma Tumor Vaccines Effects of Immu... | GeniusVac-Mel4 | 18 Years - | University Hospital, Grenoble | |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 | NCT00544258 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug) | NCT01299220 | Skin Rash | Acitretin | 18 Years - | University of Pittsburgh | |
| Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist | NCT03137511 | Patients at Ris... | Taking photogra... | 18 Years - | Nantes University Hospital | |
| ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS | NCT03822988 | Advance Directi... Oncology Skin Cancer Melanoma Skin Lymphoma Skin Squamous C... Metastatic Basa... | no intervention... | 18 Years - | Central Hospital, Nancy, France | |
| The Influence of an E-learning Program on Recognition of Actinic Keratosis | NCT05987553 | Actinic Keratos... E-learning Dermatology | e-learning prog... | 18 Years - 67 Years | Maastricht University Medical Center | |
| Evaluation of Pigmented Skin Lesions With MelaFind(R) System | NCT00434057 | Melanoma | MelaFind(R) | - | MELA Sciences, Inc. | |
| Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma | NCT06221397 | Melanoma Melanoma, Skin | 18 Years - | AI Labs Group S.L | ||
| Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses | NCT00375739 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| Clinical Validation Study of an AI-based CAD System for Early Non-Invasive Detection of Cutaneous Melanoma | NCT06221397 | Melanoma Melanoma, Skin | 18 Years - | AI Labs Group S.L | ||
| HIFU for Treatment of Non-nodular and Recurrent BCC | NCT05133427 | Carcinoma, Basa... | TOOsonix system... | 18 Years - | Bispebjerg Hospital | |
| Evaluation of Pigmented Skin Lesions With MelaFind(R) System | NCT00434057 | Melanoma | MelaFind(R) | - | MELA Sciences, Inc. | |
| Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer | NCT01459666 | Scar | Dysport (abobot... Bacteriostatic ... | 18 Years - | University Hospitals Cleveland Medical Center | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma | NCT00108121 | Basal Cell Carc... | PEP005 | 18 Years - | Peplin | |
| Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist | NCT03137511 | Patients at Ris... | Taking photogra... | 18 Years - | Nantes University Hospital | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ | NCT00329121 | Carcinoma, Squa... | PEP005 | 18 Years - | Peplin | |
| Evaluation of a Topical Treatment for Actinic Keratosis | NCT01921907 | Actinic Keratos... | AD17137 topical... Placebo | 30 Years - 90 Years | Assuta Hospital Systems | |
| High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma | NCT05698706 | Basal Cell Carc... | TOOsonix System... | 18 Years - | Old Town Clinic, Poland | |
| Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction | NCT04979078 | Hand-foot Syndr... Hand-foot Skin ... | Photobiomodulat... | 18 Years - | Jessa Hospital | |
| Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel | NCT00239135 | Keratosis | PEP005 | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | NCT00108134 | Basal Cell Carc... | PEP005 | 18 Years - | Peplin | |
| The Influence of an E-learning Program on Recognition of Actinic Keratosis | NCT05987553 | Actinic Keratos... E-learning Dermatology | e-learning prog... | 18 Years - 67 Years | Maastricht University Medical Center | |
| Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses | NCT00375739 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 | NCT00544258 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients | NCT04385732 | Melanoma Skin Cancer Anxiety and Fea... | 2D or 3D Melano... | 18 Years - | Melanoma and Skin Cancer Trials Limited | |
| To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC | NCT00432185 | Superficial Bas... | PEP005 | 18 Years - | Peplin | |
| Sildenafil for the Treatment of Lymphatic Malformations | NCT02335242 | Lymphatic Malfo... Lymphatic Disea... | Sildenafil 20 m... Placebo tablets... | 6 Months - 10 Years | Stanford University | |
| High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma | NCT05698706 | Basal Cell Carc... | TOOsonix System... | 18 Years - | Old Town Clinic, Poland | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ | NCT00329121 | Carcinoma, Squa... | PEP005 | 18 Years - | Peplin | |
| High- and Low-risk Actinic Keratosis Referrals to Secondary Care | NCT05976061 | Actinic Keratos... | 18 Years - | Maastricht University Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
